Category Archives: Defective Drugs

Inspire to Pay $5.9M over Misleading Marketing Claims for AzaSite

Inspire Pharmaceuticals, Inc. has agreed to pay $5.9 million to state and federal governments over misleading marketing claims it made about AzaSite

Read More

National Law Firm, Parker Waichman LLP, Seeks Increased Transparency and Ethics from the Pharmaceutical Industry in the New Year

In the new year, Parker Waichman LLP hopes for increased testing, safety, and efficacy in the processes and promotions used by Big Pharma so that consumers may be confident that they are receiving safe and effective medications that were ethically …

Read More

Whistleblower Cases Involving Allegations of Omnicare Swapping Scheme Settled for $124 Million

Omnicare, Inc., one of the largest pharmacy providers, has just agreed to a $124 million settlement to resolve whistleblower allegations regarding a swapping scam that involved below cost discounts and Medicare and Medicaid nursing home patients. In late June, the …

Read More

$193 Million Lidoderm Settlement Announced, Whistleblowers to Be Awarded

Three whistleblowers, among them a New York pharmaceutical sales representative, provided information to federal prosecutors, which has led to a $193 million settlement over the Lidoderm Patch being marketing for unapproved uses. A doctor and a sales representative in Pennsylvania …

Read More

Huge Awards Expected for Whistleblowers in 2014, SEC says

Large awards are awaiting whistleblowers this year, say officials from the Securities and Exchange Commission. One large award has already been given, and officials promise that more large rewards are on the way. Experts who closely follow the whistleblower issues …

Read More

Merck to Lay Off Thousands of Workers, Again

Drug maker Merck just announced it plans to lay off thousands of employees and put in place billions of dollars in cost-cutting measures over the next two years. The move, which involves the layoffs of 8,500 staff and $2.5 billion …

Read More